Development Of A Safe And Effective Tetravalent Sub-Unit Based Vaccine Candidate For Dengue Virus And Formulating The Antigenic Protein Using The Al [Oh]3 & Cpg Oligonucleotide As Adjuvants

By:

Contributor(s):

Publication details: Ooty JSSCPO 2023Description: 200DDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Barcode
M Pharm Thesis	JSS College of Pharmacy, Ooty	JSS College of Pharmacy, Ooty	Pharmaceutical Biotechnology	615.5 ANU (Browse shelf(Opens below))	Available	EPR2799

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	functional Comparison of the Cell Biology of Senescence and anti aging properties of quercetin and ascorbic acid an invitro study	DRUG REPURPOSING FOR THIOREDOXIN INTERACTING PROTEIN THROUGH MOLECULAR NETWORKING, PHARMACOPHORE MODELLING AND MOLECULAR DOCKING APPROACHES	615.5 ABI Production, Optimization, and Formulation of Sophorolipids (SLs) Biosurfactant from Starmerella bombicola	615.5 ANU Development Of A Safe And Effective Tetravalent Sub-Unit Based Vaccine Candidate For Dengue Virus And Formulating The Antigenic Protein Using The Al [Oh]3 & Cpg Oligonucleotide As Adjuvants	615.5 KAU In-Silico And In-Vitro Based Assessment Of The Antioxidant And Anti-Aging Activities Of Pyrogallol On Hdf Cell Line	615.5 NIH An explorative study on Levodopa analogues as an anti-parkinsonian - in-silico studies and in-vitro studies	615.5 SAR Investigation of Guaiazulene as a possible anti-adipogenesis agent on 3T3L-1 adipocytes in a simulated environment	Next

There are no comments on this title.

to post a comment.